Searched for
CLARIS LIFESCIENCES LIMITED
FIIs/FPIs restricted from buying more shares in Fortis, ClarisFIIs, NRIs and PIOs (Persons of Indian Origins) can invest in primary and secondary capital markets in India through Portfolio Investment S...- Thirteen stocks in focus on Friday, 16 December 2016Karnataka Bank's rights issue of one share for every two shares at Rs 70 apiece has ended with a subscription of over 185 per cent.
- Fifteen stocks in focus on Monday, 29 August 2016The Indian market is expected to open lower. Here is a list of top fifteen stocks that are likely to be in focus today.
- Fifteen stocks in focus on Monday, 22 August 2016The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.
- Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...
- Claris Lifesciences surges on ANDA approvalStocks of Claris Lifesciences climbed over 4% after one of its existing shareholders sold out its entire stake in the company via a block d...
- Claris shares surge 20%; hit upper circuit limit on bourseShares of Claris Lifesciences surged 20% amid reports that big national and international companies are in fray to buy company's injectible...
- Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 croreCarlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.
- Better business environment ups India ECB borrowings at $4.3 bn in FebruaryAs per the data, as much as $3.64 billion was raised through approval route during the month, while $661.76 million was raised by the way o...
- Twelve stocks in focus in Tuesday morning tradeIndian shares are expected to trade in a range. Here is a list of twelve stocks that are likely to be in action in morning trade today.
- No issue with exits in India: Shankar Narayanan, MD, Carlyle AsiaAt a time when global risk capital firms are increasingly reluctant to invest in the country, Carlyle Group—one of the world’s largest priv...
- Buy Claris Lifescience with a price target of Rs 280: Prakash GabaBuy Claris Lifescience with a price target of Rs 280 and a stop loss of Rs 240.
- Adani institute graduates get Rs 9.17 lakh average payCompanies like PriceWaterhouse Coopers, Tata Power Ltd and BNP Paribas Real Estate apart from Adani group companies picked up graduates fro...
- Claris receives MHRA approval for Ahmedabad unitClaris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- Best Companies To Work For 2011: Companies that came up trumps across 23 sectorsMore than 500 companies signed up for this year's survey, of which 471 met the strict eligibility criteria. A total of 67,000 employees acr...
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Claris recalls three anti-biotic drugs from USAhmedabad-based drug-maker Claris Lifesciences on Monday recalled three antibiotic drugs from the US market following an alert issued by th...
- Carlyle likely to dilute stake in Claris LifeTop private equity firm Carlyle Group is likely to partially exit Claris Lifesciences Ltd, the Rs 800-crore Ahmedabad based parenteral drug...
- 'Copycat' Indian drug cos turn MNC partnersMNCs looking to buy Indian cos are also signing up their erstwhile rivals as generics suppliers.
- Carlyle raises $668mn for Asia growth fundGlobal private equity firm Carlyle has raised $668m for its latest Asia specific growth capital fund. The fund, called the Carlyle Asia Gro...
Load More
